Advancing Novel Biotherapeutics Since 1995®
At Dyax Corp., our patients are at the center of everything we do.
Harnessing Dyax phage display technology through partnerships for therapeutic discovery.
Dyax combines a strong foundation in HAE patient care with a commitment to product development in the angioedema field.
Please see Full Prescribing Information, including Boxed Warning and Medication Guide on KALBITOR.com.
Dyax phage display technology is a rapid and robust research tool for generating highly specific potent binders to challenging therapeutic targets.